Transferring Research Into Practice For Patients With Rheumatic Diseases

A new study from the German Institute of Human Nutrition Potsdam–Rehbruecke (DIfE) and Charité – Universitätsmedizin Berlin shows for the first time that targeted control of human breathing rhythm can influence decision behavior by modulating heart…

ckert & Ziegler SE (ISIN DE0005659700, TecDAX) today officially opened the new medical isotope production site of its joint venture Qi Kang Medical Technology (Changzhou) Co., Ltd. (QKM) in the Jintan district of Changzhou, China. With the opening,…

International consortium including Germany, Poland and Ukraine evaluates the safety and efficacy of Invobenitug as a targeted therapy for septic, burn and traumatic shock, aiming to improve patient outcomes and advance critical care across Europe.

Nuvisan ICB GmbH, a fully integrated contract research organisation providing drug discovery and development services (“Nuvisan”), is pleased to announce it has received a US$25 million grant from the Gates Foundation to advance a portfolio of novel…

Pentixapharm Holding AG (Frankfurt Prime Standard: PTP), a clinical-stage biotech developing novel radiopharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for…

Application deadline 30 June 2026

Science Meets Strategy – A Decade of Innovation, Collaboration and Impact HTW Berlin – University of Applied Sciences marked a decade of its international Master's programme MBA & Engineering in Life Science Management (LSM) by bringing together…

Michael Gotthardt and his team have discovered a previously unknown genetic switch that affects RBM20, an important protein in heart cells. The findings, published in ​“Nature Communications,” suggest a potential new target for treating…